Krisa Healthcare

S.No.Dosage FormGeneric NameDetails
1 B-Complex with L-Lysine Syrup (For therapeutic use)
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Thiamine Hydrochloride I.P. 2 mg
Riboflavine Sodium Phosphate I.P. 2.5 mg
Pyridoxine Hydrochloride I.P. 0.75 mg
Nicotinamide I.P. 15 mg
D-Panthenol I.P. 3 mg
Cyanocobalamin I.P. 2 mcg
Lysine Hydrochloride I.P. 375 mg
Zinc Gluconate (eq. to elemental Zinc) USP 5 mg
Sorbitol Solution 70% (Non-crystallizing) I.P. q.s.
In a flavoured syrupy base q.s.
Excipients q.s.
Colour: Approved colour used
2 Dextromethorphan Hydrobromide, Chlorpheniramine Maleate Syrup
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Dextromethorphan Hydrobromide I.P. 5 mg
Chlorpheniramine Maleate I.P. 2 mg
Excipients q.s.
In a flavoured syrupy base q.s.
Approved Colour used
3 Dextromethorphan Hydrobromide, Chlorpheniramine Maleate and Phenylepherine Hydrochloride Syrup
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Dextromethorphan Hydrobromide I.P. 15 mg
Chlorpheniramine Maleate I.P. 2 mg
Phenylepherine Hydrochloride I.P. 5 mg
Excipients q.s.
In a palatable sugar-free base q.s.
Approved Colour used
4 Domperidone Oral Drop
Composition Standard Quantity (per 1 ml)
Each 1 ml contains :
Domperidone I.P. 10 mg
Excipients q.s.
In a flavoured syrupy base q.s.
Approved Colour used
5 Ambroxol HCl, Dextromethorphan HBR, Phenylepherine HCl, Chlorpheniramine Maleate and Menthol Syrup
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Ambroxol Hydrochloride I.P. 15 mg
Dextromethorphan Hydrobromide I.P. 10 mg
Phenylephrine Hydrochloride I.P. 5 mg
Chlorpheniramine Maleate I.P. 2 mg
Menthol I.P. 1.5 mg
Excipients q.s.
In a flavoured syrup base q.s.
Approved Colour used
6 Dried Aluminium Hydroxide Gel, Oxetacaine and Magnesium Hydroxide Syrup
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Aluminium Hydroxide (added as Dried Aluminium Hydroxide Gel 380 mg) I.P. 0.291 gm
Oxetacaine B.P. 10 mg
Magnesium Hydroxide (as Magnesium Hydroxide Paste) I.P. 98 mg
Excipients q.s.
In a flavoured palatable base q.s.
Approved colour used
7 Levosalbutamol Sulphate, Ambroxol Hydrochloride, and Guaiphenesin Oral Drops
Composition Standard Quantity (per 1 ml)
Each 1 ml contains :
Levosalbutamol Sulphate (eq. to Levosalbutamol) I.P. 0.25 mg
Ambroxol Hydrochloride I.P. 7.5 mg
Guaiphenesin I.P. 12.5 mg
Excipients q.s.
In a flavoured syrupy base q.s.
Approved Colour used
8 Cyproheptadine Hydrochloride and Tricholine Citrate Drops
Composition Standard Quantity (per 1 ml)
Each 1 ml contains :
Cyproheptadine Hydrochloride I.P. 2 mg
Tricholine Citrate (65%) 55 mg
Excipients q.s.
In a flavoured syrupy base q.s.
Approved Colour used
9 Ursodeoxycholic Acid Suspension 250mg
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Ursodeoxycholic Acid I.P. 250 mg
Excipients q.s.
In a flavoured syrup base q.s.
Approved colour used
10 Ursodeoxycholic Acid Suspension 125mg
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Ursodeoxycholic Acid I.P. 125 mg
Excipients q.s.
In a flavoured syrup base q.s.
Approved colour used
11 Paracetamol, Phenylephrine HCl, Chlorpheniramine Maleate, Sodium Citrate and Menthol syrup
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Paracetamol I.P. 125 mg
Phenylephrine Hydrochloride I.P. 5 mg
Chlorpheniramine Maleate I.P. 0.5 mg
Sodium Citrate I.P. 60 mg
Menthol I.P. 1 mg
Excipients q.s.
In a flavoured syrup base q.s.
Approved colour used
12 Milk of Magnesia, Liquid Paraffin and Sodium Picosulfate oral emulsion
Composition Standard Quantity (per 5 ml)
Each 5 ml (1 teaspoonful approx.) contains :
Milk of Magnesia I.P. 3.75 ml
Liquid Paraffin I.P. 1.25 ml
Sodium Picosulfate B.P. 3.33 mg
Excipients q.s.
Indication For symptomatic treatment of constipation in adults
Dosage As directed by the physician
Approved colour used
13 Ferric Ammonium Citrate, Folic acid and Vitamin B12 Syrup
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Ferric Ammonium Citrate (eq. to Elemental Iron) I.P. 160 mg (Elemental Iron 32.80 mg)
Folic Acid I.P. 0.5 mg
Cyanocobalamin I.P. 7.5 mcg
Excipients q.s.
In a flavoured syrupy base q.s.
Colour Approved colour used
14 Ofloxacin & Metronidazole Suspension
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Ofloxacin I.P. 100 mg
Metronidazole Benzoate (eq. to Metronidazole) I.P. 200 mg
Excipients q.s.
In a flavoured syrup base q.s.
Approved colour used
15 Azithromycin Oral Suspension
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Azithromycin (as dehydrate) eq. to Azithromycin anhydrous I.P. 100 mg
Excipients q.s.
In a flavoured syrup base q.s.
Approved colour used
16 Dill Oil, Fennel Oil with Simethicone Oral Drops
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Dill Oil B.P. 0.005 ml
Fennel Oil USP 0.0007 ml
Simethicone Emulsion (30%) eq. to Simethicone USP 40 mg
Excipients q.s.
In a flavoured syrup base q.s.
Approved colour used
17 Zinc Gluconate Oral Solution
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Zinc Gluconate (eq. to elemental Zinc) B.P. 20 mg
Excipients q.s.
In a flavoured syrup base q.s.
Approved colour used
18 Paracetamol Suspension I.P. 500 mg
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Paracetamol I.P. 500 mg
Excipients q.s.
In a flavoured syrup base q.s.
Approved colour used
19 Levetiracetam Oral Solutions I.P 500mg
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Levetiracetam I.P. 500 mg
Excipients q.s.
In a flavoured syrup base q.s.
Approved colour used
20 Ambroxol Hydrochloride Syrup 30mg
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Ambroxol Hydrochloride I.P. 30 mg
Excipients q.s.
In a flavoured syrup base q.s.
Approved colour used
21 Ranitidine Oral Solution I.P
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Ranitidine Hydrochloride (eq. to Ranitidine) I.P. 75 mg
Excipients q.s.
In a flavoured syrup base q.s.
Approved Colour used
22 Ibuprofen and Paracetamol Suspension
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Ibuprofen I.P. 100 mg
Paracetamol I.P. 162.5 mg
Excipients q.s.
In a flavoured syrup base q.s.
Approved Colour used
23 Hydroxyzine Oral Solution I.P.
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Hydroxyzine Hydrochloride I.P. 10 mg
Excipients q.s.
In a flavoured syrup base q.s.
Approved colour used
24 Paracetamol, Phenylephrine HCl, Chlorpheniramine Maleate, Sodium Citrate and Menthol Syrup
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Paracetamol I.P. 125 mg
Phenylephrine Hydrochloride I.P. 5 mg
Chlorpheniramine Maleate I.P. 0.5 mg
Sodium Citrate I.P. 60 mg
Menthol I.P. 1 mg
Excipients q.s.
In a flavoured syrup base q.s.
Approved Colour used
25 Fexofenadine Hydrochloride Suspension
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Fexofenadine Hydrochloride I.P. 60 mg
Excipients q.s.
In a flavoured syrup base q.s.
Approved colour used
26 Fexofenadine Hydrochloride Suspension
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Fexofenadine Hydrochloride I.P. 30 mg
Excipients q.s.
In a flavoured syrup base q.s.
Approved colour used
27 Phenylepherine Hydrochloride & Chlorpheniramine Maleate Syrup I.P
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Phenylephrine Hydrochloride I.P. 5 mg
Chlorpheniramine Maleate I.P. 2 mg
Excipients q.s.
In a flavoured syrup base q.s.
Approved Colour used
28 Iron, Vitamin B12 and Folic Acid Syrup
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Ferric Ammonium Citrate (eq. to elemental Iron) I.P. 110.55 mg
Folic Acid I.P. 1.5 mg
Cyanocobalamin I.P. 15 mcg
In a flavoured syrupy base q.s.
Excipients q.s.
Colour: Approved colour used
29 Pyridoxine Hydrochloride, Nicotinamide, Cyanocobalamin and Lysine Hydrochloride Syrup
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Pyridoxine Hydrochloride I.P. 0.75 mg
Nicotinamide I.P. 15 mg
Cyanocobalamin I.P. 2 mcg
Lysine Hydrochloride I.P. 37.5 mg
In a flavoured syrupy base q.s.
Excipients q.s.
Colour: Approved colour used
30 Liquid Paraffin & Milk of Magnesia Suspension
Composition Standard Quantity (per 15 ml)
Each 15 ml contains :
Liquid Paraffin I.P. 3.75 ml
Milk of Magnesia I.P. 11.25 ml
Excipients q.s.
In a flavoured syrupy base q.s.
Approved colour used
31 Promethazine Syrup I.P
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Promethazine Hydrochloride I.P. 5 mg
Excipients q.s.
In a flavoured syrupy base q.s.
Approved colour used
32 Levocetirizine Dihydrochloride Syrup
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Levocetirizine Dihydrochloride I.P. 2.5 mg
Excipients q.s.
In a flavoured syrupy base q.s.
Approved colour used
33 Levodropropizine & Chlorpheniramine Maleate Syrup
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Levodropropizine I.P. 30 mg
Chlorpheniramine Maleate I.P. 2 mg
Excipients q.s.
Approved Colour used
34 Diphenhydramine HCl, Ammonium Chloride, Sodium Citrate and Menthol Syrup
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Diphenhydramine Hydrochloride I.P. 14.08 mg
Ammonium Chloride I.P. 138 mg
Sodium Citrate I.P. 57.03 mg
Menthol I.P. 1.14 mg
Excipients q.s.
In a flavoured syrup base q.s.
Approved Colour used
35 Potassium Citrate, Magnesium Citrate & Pyridoxine HCl Oral Solution
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Potassium Citrate I.P. 1100 mg
Magnesium Citrate USP 375 mg
Pyridoxine Hydrochloride I.P. 20 mg
Excipients q.s.
In a flavoured syrup base q.s.
Approved Colour used
36 Calcium, Magnesium, Zinc & Vitamin D3 Suspension
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Calcium Carbonate (eq. to elemental Calcium) I.P. 625 mg
Magnesium Hydroxide (eq. to elemental Magnesium) I.P. 75 mg
Zinc Gluconate (eq. to elemental Zinc) USP 2 mg
Vitamin D3 I.P. 200 I.U.
Excipients q.s.
In a flavoured syrup base q.s.
Approved Colour used
37 Sodium Alginate, Sodium Bicarbonate and Calcium Carbonate Suspension
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Sodium Alginate I.P. 250 mg
Sodium Bicarbonate I.P. 133.5 mg
Calcium Carbonate I.P. 80 mg
Excipients q.s.
In a flavoured syrup base q.s.
Approved colour used
38 Dried Aluminium Hydroxide, Magnesium Hydroxide, Simethicone Suspension
Composition Standard Quantity (per 10 ml)
Each 10 ml contains :
Dried Aluminium Hydroxide I.P. 250 mg
Magnesium Hydroxide I.P. 250 mg
Simethicone I.P. 50 mg
Excipients q.s.
In a flavoured syrup base q.s.
Approved colour used
39 Chlorhexidine Gluconate Mouth Wash IP
Composition Standard Quantity
Chlorhexidine Gluconate I.P. 0.2% w/v
In a pleasantly flavoured syrupy base q.s.
Approved colour used
40 Paracetamol, Cetirizine HCl, Phenylephrine HCl and Menthol Suspension
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Paracetamol I.P. 250 mg
Cetirizine Hydrochloride I.P. 2.5 mg
Phenylephrine Hydrochloride I.P. 2.5 mg
Menthol I.P. 1 mg
Excipients q.s.
In a flavoured syrupy base q.s.
Approved colour used
41 Cetirizine HCl, Phenylephrine HCl and Paracetamol Suspension
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Cetirizine Hydrochloride I.P. 2.5 mg
Phenylephrine Hydrochloride I.P. 5 mg
Paracetamol I.P. 125 mg
Excipients q.s.
In a flavoured syrupy base q.s.
Approved colour used
42 Levocloperastine Fendizoate Oral Suspension
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Levocloperastine Fendizoate (eq. to Levocloperastine Hydrochloride) 20 mg
Excipients q.s.
In a flavoured syrup base q.s.
Approved Colour used
43 Paracetamol, Phenylephrine & Chlorpheniramine Maleate Suspension
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Paracetamol I.P. 250 mg
Phenylephrine Hydrochloride I.P. 5 mg
Chlorpheniramine Maleate I.P. 2 mg
Excipients q.s.
In a flavoured syrup base q.s.
Approved Colour used
44 Fungal Diastase and Pepsin Syrup
Composition Standard Quantity (per 15 ml)
Each 15 ml contains :
Fungal Diastase (1:1200) (Derived from Aspergillus oryzae, digest not less than 60 gm of cooked starch) I.P. 50 mg
Pepsin (1:3000) (Digest not less than 60 gm of coagulated egg albumin) I.P. 10 mg
Excipients q.s.
In a Flavoured Palatable base q.s.
Approved Colour used
Dosage:
Adult: One teaspoonful immediately after the meal.
Children: Half the adult dose.
As directed by the physician.
45 Sucralfate and Oxetacaine Suspension
Composition Standard Quantity (per 10 ml)
Each 10 ml contains :
Sucralfate USP 1000 mg
Oxetacaine B.P. 20 mg
Excipients q.s.
In a flavoured syrup base q.s.
Approved colour used
46 Lactulose Oral Solution U.S.P.
Composition Standard Quantity (per 15 ml)
Each 15 ml contains :
Lactulose Concentrate (eq. to Lactulose 66% w/v) USP 10 gm
In a flavoured syrup base q.s.
Excipients q.s.
Approved colour used
47 Mefenamic Acid and Paracetamol Suspension
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Mefenamic Acid I.P. 100 mg
Paracetamol I.P. 250 mg
In Flavoured syrup base q.s.
Approved colour used
48 Di-Sodium Hydrogen Citrate Syrup
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Di-Sodium Hydrogen Citrate B.P. 1.37 gm
Excipients q.s.
In a flavoured syrup base q.s.
Approved colour used
49 Ofloxacin, Metronidazole Benzoate and Simethicone Suspension
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Ofloxacin I.P. 50 mg
Metronidazole Benzoate (eq. to Metronidazole) I.P. 120 mg
Simethicone I.P. 10 mg
Excipients q.s.
In a flavoured syrup base q.s.
Approved Colour used
50 Sodium Picosulfate Oral Solution B.P.
Composition Standard Quantity (per 5 ml)
Each 5 ml (1 teaspoonful approx.) contains :
Sodium Picosulfate B.P. 5 mg
Excipients q.s.
Dosage: As directed by the physician.
Approved Colour used
51 Milk of Magnesia, Liquid Paraffin and Sodium Picosulfate oral emulsion
Composition Standard Quantity (per 5 ml)
Each 5 ml (1 teaspoonful approx.) contains :
Sodium Picosulfate B.P. 33.3 mg
Liquid Paraffin I.P. 1.25 ml
Milk of Magnesia I.P. 3.75 ml
Excipients q.s.
Indication: For symptomatic treatment of constipation in adults.
Dosage: As directed by the physician.
Approved Colour used
52 Dried Aluminium Hydroxide, Magnesium Hydroxide, Simethicone and Oxetacaine Syrup
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Dried Aluminium Hydroxide Gel (eq. to Aluminium Hydroxide) I.P. 600 mg
Magnesium Hydroxide I.P. 300 mg
Simethicone I.P. 25 mg
Oxetacaine B.P. 10 mg
Purified Water I.P. q.s.
Excipients q.s.
In a flavoured syrup base q.s.
Approved colour used
53 Ofloxacin Oral Suspension I.P. 100mg
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Ofloxacin I.P. 100 mg
Excipients q.s.
In a flavoured syrup base q.s.
Approved colour used
54 Ondansetron Oral Solution I.P. 2 mg
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Ondansetron Hydrochloride (eq. to Ondansetron) I.P. 2 mg
Excipients q.s.
In a flavoured syrup base q.s.
Approved colour used
55 Paracetamol Paediatric Oral Suspension I.P. 250mg
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Paracetamol I.P. 250 mg
Excipients q.s.
In a flavoured syrup base q.s.
Approved colour used
56 Paracetamol Paediatric Oral Suspension I.P. 125mg
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Paracetamol I.P. 125 mg
Excipients q.s.
In a flavoured syrup base q.s.
Approved colour used
57 Magaldrate and Simethicone Oral Suspension I.P.
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Magaldrate (Anhydrous) I.P. 400 mg
Simethicone I.P. 60 mg
In a suspension base
Excipients q.s.
Approved Colour used
58 Mefenamic Acid and Paracetamol Suspension
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Mefenamic Acid I.P. 50 mg
Paracetamol I.P. 125 mg
Excipients q.s.
In a flavoured syrup base q.s.
Approved Colour used
59 Vitamin D3 oral Solution 60000 I.U (Nano Shot)
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Cholecalciferol (Vitamin D3) (In nano droplet form) I.P. 60,000 I.U.
In a flavoured sorbitol base q.s.
Colour: Tartrazine Supra
60 Ambroxol Hydrochloride, Levosalbutamol Sulphate and Guaiphenesin Syrup
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Ambroxol Hydrochloride I.P. 15 mg
Levosalbutamol Sulphate (eq. to Levosalbutamol) I.P. 0.50 mg
Guaiphenesin I.P. 50 mg
Excipients q.s.
In a flavoured syrup base q.s.
Approved Colour used
61 Lycopene Enriched with Antioxidants, Multivitamin and Multimineral Syrup
Composition Standard Quantity (per 10 ml)
Each 10 ml contains :
Lycopene 10% USP 2000 mcg
Niacinamide I.P. 25 mg
Folic Acid I.P. 100 mcg
Selenium Dioxide Monohydrate (eq. to Selenium) B.P. 35 mcg
Zinc (as Zinc Gluconate USP) 3 mg
Iodine (as Potassium Iodide IP) 100 mcg
Copper (as Cupric Sulphate USP) 500 mcg
Vitamin B12 I.P. 1 mcg
Vitamin B6 I.P. 1.5 mg
Excipients q.s.
In a flavoured base q.s.
Appropriate overages of vitamins added to compensate for any loss on storage
Approved colour used
62 Aceclofenac and Paracetamol Suspension
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Aceclofenac I.P. 50 mg
Paracetamol I.P. 125 mg
Excipients q.s.
In a flavoured syrup base q.s.
Approved Colour used
63 Calcium Citrate Malate, Magnesium, Zinc,Vitamin D3, Methylcobalamin, L-Methylfolate Calcium & Pyridoxal-5 Phosphate Tablets
Composition Standard Quantity
Each film coated tablet contains :
Calcium Citrate Malate (eq. to elemental Calcium) I.P. 1250/250 mg
Magnesium Hydroxide (eq. to elemental Magnesium) I.P. 75 mg
Zinc Sulphate Monohydrate (eq. to elemental Zinc) I.P. 5 mg
Vitamin D3 (as stabilized) I.P. 2000 IU
Methylcobalamin I.P. 1500 mcg
L-Methylfolate Calcium USP 1 mg
Pyridoxal-5 Phosphate 20 mg
Excipients q.s.
Approved colour used
64 Vitamin D3 (Cholecalciferol) Drops
Composition Standard Quantity (per ml)
Each 1 ml contains :
Vitamin D3 (Cholecalciferol) I.P. 800 IU
Excipients q.s.
In a flavoured Palatable base q.s.
Approved Colour used
65 Fungal Diastase and Pepsin syrup
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Fungal Diastase (1:1200)
(Derived from Aspergillus oryzae, digest not less than 60 gm of cooked starch)		 I.P. 50 mg
Pepsin (1:3000)
(Digest not less than 60 gm of coagulated egg albumin)		 I.P. 10 mg
Excipients q.s.
In a Flavoured Palatable base q.s.
Approved Colour used
Dosage:
Adult: One teaspoonful immediately after the meal.
Children: Half the adult dose.
As directed by the physician.
66 Clarithromycin Tablets I.P. 500 mg
Composition Standard Quantity
Each film coated tablet contains :
Clarithromycin I.P. 500 mg
Excipients q.s.
Approved Colour used
67 Azithromycin Oral Suspension I.P.
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Azithromycin Dihydrate (eq. to anhydrous Azithromycin) I.P. 200 mg
Excipients q.s.
In a flavoured syrup base q.s.
Approved colour used
68 Cilnidipine Tablets I.P 10 mg
Composition Standard Quantity
Each film coated tablet contains :
Cilnidipine I.P. 10 mg
Excipients q.s.
Approved Colour used
69 Ferrous Ascorbate And Folic Acid Suspension
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Ferrous Ascorbate (eq. to elemental iron) 30 mg
Folic Acid I.P. 550 mcg
Excipients q.s.
In a flavoured syrup base q.s.
Approved Colour used
70 Linagliptin Tablets 5 mg
Composition Standard Quantity
Each film coated tablet contains :
Linagliptin 5 mg
Excipients q.s.
Approved Colour used
71 Terbutaline Sulphate, Bromhexine Hydrochloride, Guiaphenesin and Menthol Syrup
Composition Standard Quantity (per 5 ml)
Each 5 ml (one teaspoonful) contains :
Terbutaline Sulphate I.P. 1.25 mg
Bromhexine Hydrochloride I.P. 4 mg
Guaiphenesin I.P. 50 mg
Menthol I.P. 1 mg
Excipients q.s.
In a flavoured syrup base q.s.
Approved colour used
72 Sitagliptin Phosphate Tablets I.P 100mg
Composition Standard Quantity
Each film coated tablet contains :
Sitagliptin Phosphate Monohydrate
(Eq. to Sitagliptin)		 I.P. 100 mg
Excipients q.s.
Approved Colour used
73 Piracetam Syrup
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Piracetam I.P. 500 mg
Excipients q.s.
In a flavoured syrup base q.s.
Approved colour used
74 Sitagliptin Phosphate Tablets I.P 50mg
Composition Standard Quantity
Each film coated tablet contains :
Sitagliptin Phosphate Monohydrate
(Eq. to Sitagliptin)		 I.P. 50 mg
Excipients q.s.
Approved Colour used
75 Febuxostat Tablets 20 mg
Composition Standard Quantity
Each film coated tablet contains :
Febuxostat 20 mg
Excipients q.s.
Approved Colour used
76 Fenofibrate Tablets I.P 160 mg
Composition Standard Quantity
Each film coated tablet contains :
Fenofibrate I.P. 160 mg
Excipients q.s.
Approved colour used
77 Montelukast Sodium and Levocetirizine Dihydrochloride Suspension (For Paediatric Use Only)
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Montelukast Sodium (eq. to Montelukast) I.P. 4 mg
Levocetirizine Dihydrochloride I.P. 2.5 mg
Excipients q.s.
In a flavoured syrup base q.s.
Colour: Approved colour used
78 Fenofibrate Tablets I.P 145mg
Composition Standard Quantity
Each film coated tablet contains :
Fenofibrate I.P. 145 mg
Excipients q.s.
Approved colour used
79 Etamsylate & Tranexamic Acid Tablets
Composition Standard Quantity
Each film coated tablet contains :
Etamsylate B.P. 250 mg
Tranexamic Acid I.P. 250 mg
Excipients q.s.
Approved Colour used
80 Amlodipine Besylate and Metoprolol Succinate (ER)Tablets
Composition Standard Quantity
Each uncoated tablet contains :
Amlodipine Besylate
(Eq. to Amlodipine)		 I.P. 5 mg
Metoprolol Succinate
(eq. to Metoprolol Tartrate, Extended Released)		 I.P. 23.75 mg/25 mg
Excipients q.s.
Approved Colour used
81 Ferrous Ascorbate & Folic Acid Tablets I.P
Composition Standard Quantity
Each film coated tablet contains :
Ferrous Ascorbate
(eq. to elemental iron)		 I.P. 100 mg
Folic Acid I.P. 1.5 mg
Excipients q.s.
Approved Colour used
82 Disulfiram Tablets I.P 500mg
Composition Standard Quantity
Each uncoated tablet contains :
Disulfiram I.P. 500 mg
Excipients q.s.
Approved colour used
83 Disulfiram Tablets I.P 250mg
Composition Standard Quantity
Each uncoated tablet contains :
Disulfiram I.P. 250 mg
Excipients q.s.
Approved colour used
84 Ursodeoxycholic Acid SR Tablets 300mg
Composition Standard Quantity
Each film coated sustained release tablet contains :
Ursodeoxycholic Acid I.P. 300 mg
Excipients q.s.
Approved colour used
85 Etoricoxib and Thiocolchicoside Tablets
Composition Standard Quantity
Each film coated tablet contains :
Etoricoxib I.P. 60 mg
Thiocolchicoside I.P. 8 mg
Excipients q.s.
86 Piracetam Tablets
Composition Standard Quantity
Each film coated tablet contains :
Piracetam I.P. 800 mg
Excipients q.s.
Approved Colour used
87 Rifaximin Tablets 550mg
Composition Standard Quantity
Each film coated tablet contains :
Rifaximin I.P. 550 mg
Excipients q.s.
Approved colour used
88 Rifaximin Tablets 400mg
Composition Standard Quantity
Each film coated tablet contains :
Rifaximin I.P. 400 mg
Excipients q.s.
Approved colour used
89 Rifaximin Tablets 200mg
Composition Standard Quantity
Each film coated tablet contains :
Rifaximin I.P. 200 mg
Excipients q.s.
Approved colour used
90 Telmisartan and Amlodipine Besilate Tablets I.P
Composition Standard Quantity
Each uncoated bilayered tablet contains :
Telmisartan I.P. 40 mg
Amlodipine Besilate
(eq. to Amlodipine)		 I.P. 5 mg
Excipients q.s.
91 Rifaximin Tabs 200mg

Each unc

Composition Standard Quantity
Each uncoated tablet contains :
Rifaximin 200 mg
Excipients q.s.
Approved colour used
92 Rifaximin Tabs 400mg
Composition Standard Quantity
Each uncoated tablet contains :
Rifaximin 400 mg
Excipients q.s.
Approved colour used
93 Metronidazole & Furazolidone Bolus (only veterinary use)
Composition Standard Quantity
Each bolus contains :
Metronidazole I.P. 1 g
Furazolidone I.P. 200 mg
Excipients q.s.
Approved colour used
94 Sulphadiazine & Trimethoprim Bolus I.P. (only veterinary use)
Composition Standard Quantity
Each bolus contains :
Sulphadiazine I.P. 1000 mg
Trimethoprim I.P. 200 mg
Excipients q.s.
Approved colour used
95 Flunixin Meglumine & Serratiopeptidase Bolus (only veterinary use)
Composition Standard Quantity
Each uncoated bolus contains :
Flunixin Meglumine
(eq. to Flunixin)		 I.P. 1000 mg
Serratiopeptidase
(eq. to enzyme activity 2,00,000 units, as enteric coated granules)		 I.P. 100 mg
Excipients q.s.
Approved Colour used
96 Oxfendazole Bolus (only veterinary use)
Composition Standard Quantity
Each uncoated bolus contains :
Oxfendazole I.P. 2200 mg
Excipients q.s.
Approved Colour used
97 Calcium Carbonate, Vitamin D3, Methylcobalamin, L-Methylfolate Calcium & Pyridoxal-5 Phosphate Tablets
Composition Standard Quantity
Each film coated tablet contains :
Calcium Carbonate
(Eq. to Elemental Calcium)		 I.P. 500 mg
Vitamin D3 I.P. 2000 IU
Methylcobalamin I.P. 1500 mcg
L-Methylfolate Calcium 1 mg
Pyridoxal-5 Phosphate 20 mg
Excipients q.s.
Approved Colour used
98 Calcium, Vitamin D3, Methylcobalamin, L-Methylfolate Calcium & Pyridoxal-5 Phosphate Tablets
Composition Standard Quantity
Each film coated tablet contains :
Calcium Carbonate
(from an Organic source of Oyster Shell)
Eq. to Elemental Calcium		 I.P. 500 mg
Vitamin D3 I.P. 2000 IU
Methylcobalamin I.P. 1500 mcg
L-Methylfolate Calcium 1 mg
Pyridoxal-5 Phosphate 0.5 mg
Excipients q.s.
Approved Colour used
99 Clomipramine HCl Tablets
Composition Standard Quantity
Each film coated tablet contains :
Clomipramine Hydrochloride I.P. 50 mg
Excipients q.s.
Approved Colour used
100 Fluvoxamine Maleate Tablets I.P 100 mg.
Composition Standard Quantity
Each film coated tablet contains :
Fluvoxamine Maleate I.P. 100 mg
Excipients q.s.
Approved Colour used
101 Fluvoxamine Maleate Tablets I.P 50 mg.
Composition Standard Quantity
Each film coated tablet contains :
Fluvoxamine Maleate I.P. 50 mg
Excipients q.s.
Approved Colour used
102 Procyclidine HCl Tablets I.P 5mg.
Composition Standard Quantity
Each uncoated tablet contains :
Procyclidine Hydrochloride I.P. 5 mg
Excipients q.s.
Approved Colour used
103 Eperisone HCl Tablets
Composition Standard Quantity
Each film coated tablet contains :
Eperisone Hydrochloride 50 mg
Excipients q.s.
Approved Colour used
104 Methylcobalamin, Alpha Lipoic Acid, Benfotiamine, Folic Acid, Chromium Polynicotinate, Inositol, Pyridoxine HCl, Vitamin D3 & Calcium Carbonate Tablets
Composition Standard Quantity
Each film coated tablet contains :
Methylcobalamin I.P. 1500 mcg
Alpha Lipoic Acid I.P. 100 mg
Benfotiamine USP 150 mg
Folic Acid I.P. 1.5 mg
Chromium Polynicotinate 200 mcg
Inositol I.P. 100 mg
Pyridoxine Hydrochloride I.P. 3 mg
Vitamin D3 I.P. 1000 IU
Calcium Carbonate I.P. 500 mg
Excipients q.s.
Approved Colour used
105 Dapagliflozin and Metformin HCl (ER) Tablets
Composition Standard Quantity
Each film coated tablet contains :
Dapagliflozin Propanediol Monohydrate
(Eq. to Dapagliflozin)		 10 mg
Metformin HCl
(as extended release form)		 I.P. 500 mg
Excipients q.s.
Approved Colour used
106 Vildagliptin Tablets I.P 50 mg
Composition Standard Quantity
Each uncoated tablet contains :
Vildagliptin I.P. 50 mg
Excipients q.s.
Approved Colour used
107 Rosuvastatin and Fenofibrate Tablets
Composition Standard Quantity
Each film coated tablet contains :
Rosuvastatin Calcium
(eq. to Rosuvastatin)		 I.P. 10 mg
Fenofibrate I.P. 145 mg
Excipients q.s.
Approved Colour used
108 Bilastine and Montelukast Tablets
Composition Standard Quantity
Each film coated tablet contains :
Bilastine I.P. 20 mg
Montelukast Sodium
(Eq. to Montelukast)		 10 mg
Excipients q.s.
Approved Colour used
109 Duloxetine Gastro-resistant Tablets I.P. 30mg
Composition Standard Quantity
Each enteric coated tablet contains :
Duloxetine Hydrochloride
(eq. to Duloxetine)		 I.P. 30 mg
Excipients q.s.
Approved Colour used
110 Duloxetine Gastro-resistant Tablets I.P. 20mg
Composition Standard Quantity
Each enteric coated tablet contains :
Duloxetine Hydrochloride
(eq. to Duloxetine)		 I.P. 20 mg
Excipients q.s.
Approved Colour used
111 Naproxen Tablets I.P 500mg
Composition Standard Quantity
Each uncoated tablet contains :
Naproxen I.P. 500 mg
Excipients q.s.
Approved Colour used
112 Propranolol Hydrochloride Tablets I.P 40mg
Composition Standard Quantity
Each uncoated tablet contains :
Propranolol Hydrochloride I.P. 40 mg
Excipients q.s.
Approved Colour used
113 Tadalafil Tablets I.P 10mg
Composition Standard Quantity
Each film coated tablet contains :
Tadalafil I.P. 10 mg
Excipients q.s.
Approved Colour used
114 Drotaverine Hydrochloride Tablets I.P 40mg
Composition Standard Quantity
Each film coated tablet contains :
Drotaverine Hydrochloride I.P. 40 mg
Excipients q.s.
Approved Colour used
115 Gabapentin Tablets I.P 300 mg
Composition Standard Quantity
Each film coated tablet contains :
Gabapentin I.P. 300 mg
Excipients q.s.
Approved Colour used
116 Gabapentin Tablets I.P 100 mg
Composition Standard Quantity
Each film coated tablet contains :
Gabapentin I.P. 100 mg
Excipients q.s.
Approved Colour used
117 Rosuvastatin Calcium and Ezetimibe Tablets I.P.
Composition Standard Quantity
Each film coated tablet contains :
Rosuvastatin Calcium
(eq. to Rosuvastatin)		 I.P. 40 mg
Ezetimibe I.P. 10 mg
Excipients q.s.
Approved Colour used
118 Rosuvastatin Calcium and Ezetimibe Tablets I.P.
Composition Standard Quantity
Each film coated tablet contains :
Rosuvastatin Calcium
(eq. to Rosuvastatin)		 I.P. 20 mg
Ezetimibe I.P. 10 mg
Excipients q.s.
Approved Colour used
119 Amlodipine Besylate and Metoprolol Succinate (ER) Tablets
Composition Standard Quantity
Each uncoated bilayered tablet contains :
Amlodipine Besylate
(Eq. to Amlodipine)		 I.P. 5 mg
Metoprolol Succinate
(Eq. to Metoprolol Tartrate, extended release)		 I.P. 47.50 mg / 50 mg
Excipients q.s.
Approved Colour used
120 Voglibose and Metformin Hydrochloride (SR) Tablets
Composition Standard Quantity
Each uncoated bilayered tablet contains :
Voglibose I.P. 0.3 mg
Metformin Hydrochloride (sustained released) I.P. 500 mg
Excipients q.s.
Approved Colour used
121 Amitriptyline Hydrochloride Tablets I.P
Composition Standard Quantity
Each film coated tablet contains :
Amitriptyline Hydrochloride I.P. 50 mg
Excipients q.s.
Approved Colour used
122 Amitriptyline Hydrochloride Tablets I.P
Composition Standard Quantity
Each film coated tablet contains :
Amitriptyline Hydrochloride I.P. 25 mg
Excipients q.s.
Approved Colour used
123 Amitriptyline Hydrochloride Tablets I.P
Composition Standard Quantity
Each film coated tablet contains :
Amitriptyline Hydrochloride I.P. 10 mg
Excipients q.s.
Approved Colour used
124 Flavoxate Hydrochloride Tablets I.P 200mg
Composition Standard Quantity
Each film coated tablet contains :
Flavoxate Hydrochloride I.P. 200 mg
Excipients q.s.
Approved Colour used
125 Telmisartan 40 mg & Cilnidipine 10 mg Tablets
Composition Standard Quantity
Each film coated tablet contains :
Telmisartan I.P. 40 mg
Cilnidipine I.P. 10 mg
Excipients q.s.
Approved Colour used
126 Ginkgo biloba Dry Extract Tablets I.P
Composition Standard Quantity
Each film coated tablet contains :
Ginkgo biloba dry extract
(containing 9.6 mg of ginkgo flavone glycosides)		 I.P. 40 mg
Excipients q.s.
Approved colour used
127 L-Carnitine L-Tartrate, Methylcobalamin & Folic Acid Tablets
Composition Standard Quantity
Each film coated tablet contains :
L-Carnitine L-Tartrate
Eq. to L-Carnitine		 500 mg
Methylcobalamin I.P. 1500 mcg
Folic Acid 1.5 mg
Excipients q.s.
Approved colour used
128 Methylcobalamin, L-Methyl Folate & Pyridoxal-5 Phosphate Tablets
Composition Standard Quantity
Each film coated tablet contains :
Methylcobalamin I.P. 1500 mcg
L-5 Methyltetrahydrofolate Calcium
(eq. to L-Methyl Folate)		 1 mg
Pyridoxal-5 Phosphate 0.5 mg
Excipients q.s.
Approved colour used
129 Esomeprazole Gastro-resistant Tablets I.P 40mg
Composition Standard Quantity
Each enteric coated tablet contains :
Esomeprazole Magnesium Trihydrate
(eq. to Esomeprazole)		 I.P. 40 mg
Excipients q.s.
Approved colour used
130 Esomeprazole Gastro-resistant Tablets I.P 20mg
Composition Standard Quantity
Each enteric coated tablet contains :
Esomeprazole Magnesium Trihydrate
(eq. to Esomeprazole)		 I.P. 20 mg
Excipients q.s.
Approved colour used
131 Citicoline and Piracetam Tablets
Composition Standard Quantity
Each film coated tablet contains :
Citicoline Sodium
(eq. to Citicoline)		 I.P. 500 mg
Piracetam I.P. 800 mg
Excipients q.s.
Approved Colour used
132 Ambroxol Hydrochloride, Levocetirizine Hydrochloride, Guaiphenesin and Menthol Syrup
Composition Standard Quantity
Each 5 ml contains:
Ambroxol Hydrochloride I.P. 15 mg
Levocetirizine Hydrochloride I.P. 2.5 mg
Guaiphenesin I.P. 50 mg
Menthol I.P. 1 mg
In a flavoured syrup base q.s.
Excipients q.s.
Colour Approved colour used
133 Magaldrate and Simethicone Oral Suspension U.S.P.
Composition Standard Quantity
Each 5 ml contains:
Magaldrate (anhydrous) I.P. 400 mg
Simethicone I.P. 20 mg
Sorbitol Solution 70% (Non-crystallizing) I.P. q.s.
Purified Water I.P. q.s.
Excipients q.s.
Approved Colour used
Dosage:
Adults & Children over 12 years: 1–2 teaspoonfuls between meals & at bedtime.
Children 5–12 years: Half of the above dose or as directed by the physician.
134 Dextromethorphan Hydrobromide, Chlorpheniramine Maleate and Phenylepherine Hydrochloride Syrup
Composition Standard Quantity
Each 5 ml (one teaspoonful) contains :
Dextromethorphan Hydrobromide I.P. 10 mg
Chlorpheniramine Maleate I.P. 2 mg
Phenylephrine Hydrochloride I.P. 5 mg
Excipients q.s.
In a flavoured syrup base q.s.
Approved Colour used
Dosage:
Adults: 10 ml, 3–4 times a day
Children (2–6 years): 2.5 ml, 3–4 times a day
Children (6–12 years): 5 ml, 3–4 times a day
135 Rosuvastatin Calcium Tablets I.P. 40 mg
Composition Standard Quantity
Each film coated tablet contains :
Rosuvastatin Calcium
(eq. to Rosuvastatin)		 I.P. 40 mg
Excipients q.s.
Approved Colour used
136 Cyproheptadine Hydrochloride and Tricholine Citrate Syrup
Composition Standard Quantity
Each 5 ml contains :
Cyproheptadine Hydrochloride (anhydrous) I.P. 2 mg
Tricholine Citrate (65%) 275 mg
Sorbitol Solution 70% (Non-crystallizing) I.P. q.s.
Excipients q.s.
In a Flavoured Syrup base q.s.
Approved Colour used
137 Terbutaline Sulphate, Ambroxol Hydrochloride, Guaiphenesin and Menthol Syrup
Composition Standard Quantity
Each 5 ml contains :
Terbutaline Sulphate I.P. 2.5 mg
Ambroxol Hydrochloride I.P. 30 mg
Guaiphenesin I.P. 100 mg
Menthol I.P. 2.5 mg
Excipients q.s.
In a flavoured syrup base q.s.
Approved Colour used
138 Deflazacort Oral Suspension
Composition Standard Quantity
Each 5 ml contains :
Deflazacort 6 mg
In a flavoured syrup base q.s.
Excipients q.s.
Approved Colour used
139 Ambroxol Hydrochloride, Levosalbutamol Sulphate and Guaiphenesin Syrup
Composition Standard Quantity
Each 5 ml contains :
Ambroxol Hydrochloride I.P. 30 mg
Levosalbutamol Sulphate eq. to Levosalbutamol I.P. 1 mg
Guaiphenesin I.P. 50 mg
Excipients q.s.
In a flavoured syrup base q.s.
Approved colour used
140 Paracetamol, Phenylephrine HCl, Chlorpheniramine Maleate, Sodium Citrate and Menthol syrup Tablets
Composition Standard Quantity
Each uncoated tablet contains :
Paracetamol I.P. 125 mg
Phenylephrine Hydrochloride I.P. 5 mg
Chlorpheniramine Maleate I.P. 0.5 mg
Sodium Citrate I.P. 60 mg
Menthol I.P. 1 mg
Excipients q.s.
In a flavoured syrup base q.s.
Approved Colour used
141 Metformin Hydrochloride Sustained Released Tablets I.P.
Composition Standard Quantity
Each uncoated sustained release tablet contains :
Metformin Hydrochloride I.P. 1000 mg
Excipients q.s.
Approved Colour used
142 Ambroxol Hydrochloride, Terbutaline Sulphate, Guaiphenesin and Menthol Syrup
Composition Standard Quantity (per 5 ml)
Each 5 ml contains :
Ambroxol Hydrochloride I.P. 15 mg
Terbutaline Sulphate I.P. 1.25 mg
Guaiphenesin I.P. 50 mg
Menthol I.P. 2.5 mg
Excipients q.s.
In a flavoured syrup base q.s.
Approved Colour used
143 Dextromethorphan Hydrobromide, Chlorpheniramine Maleate and Phenylepherine Hydrochloride Tablets
Composition Standard Quantity
Each uncoated tablet contains :
Dextromethorphan Hydrobromide I.P. 10 mg
Chlorpheniramine Maleate I.P. 2 mg
Phenylepherine Hydrochloride I.P. 5 mg
Excipients q.s.
Colour: Ponceau-4R
144 Lansoprazole Orally Disintegrating Tablets
Composition Standard Quantity
Each uncoated tablet contains :
Lansoprazole
(as enteric coated pellets)		 I.P. 15 mg
Excipients q.s.
Approved Colour used
145 Aceclofenac and Paracetamol Tablets
Composition Standard Quantity
Each uncoated tablet contains :
Aceclofenac I.P. 100 mg
Paracetamol I.P. 325 mg
Excipients q.s.
Approved Colour used
146 Fexofenadine and Montelukast Tablets
Composition Standard Quantity
Each film coated tablet contains :
Fexofenadine Hydrochloride I.P. 120 mg
Montelukast Sodium
(eq. to Montelukast)		 I.P. 10 mg
Excipients q.s.
Approved Colour used
147 Telmisartan 40 mg and Chlorthalidone 12.5 mg Tablets
Composition Standard Quantity
Each film coated tablet contains :
Telmisartan I.P. 40 mg
Chlorthalidone I.P. 12.5 mg
Excipients q.s.
Approved Colour used
148 Silodosin 8mg & Dutasteride 0.5mg Capsules
Composition Standard Quantity
Each hard gelatin capsule contains :
Silodosin 8 mg
Dutasteride (as uncoated tablet) I.P. 0.5 mg
Excipients q.s.
Approved colour used in empty capsule shells
149 Diacerein Capsules 50mg I.P
Composition Standard Quantity
Each hard gelatin capsule contains :
Diacerein I.P. 50 mg
Excipients q.s.
Approved colour used in empty capsule shells
150 Telmisartan 80 mg and Chlorthalidone 12.5 mg Tablets
Composition Standard Quantity
Each film coated tablet contains :
Telmisartan I.P. 80 mg
Chlorthalidone I.P. 12.5 mg
Excipients q.s.
Approved Colour used
151 Calcium Dobesilate Capsules 500 mg.
Composition Standard Quantity
Each hard gelatin capsule contains :
Calcium Dobesilate Monohydrate I.P. 500 mg
Excipients q.s.
Approved colour used in empty capsule shells
152 Metoprolol Succinate (ER) Tablets I.P.
Composition Standard Quantity
Each uncoated extended release tablet contains :
Metoprolol Succinate
(eq. to Metoprolol Tartrate, extended release)		 I.P. 50 mg
(Metoprolol Succinate actual strength) I.P. 47.50 mg
Excipients q.s.
Approved Colour used
153 Alpha Lipoic Acid, Methylcobalamin, Pyridoxine Hydrochloride, Folic Acid, Benfotiamine, Chromium Picolinate & Biotin Capsules
Composition Standard Quantity
Each hard gelatin capsule contains :
Alpha Lipoic Acid USP 100 mg
Methylcobalamin I.P. 1500 mcg
Pyridoxine Hydrochloride I.P. 3 mg
Folic Acid I.P. 1.5 mg
Benfotiamine I.P. 50 mg
Chromium Picolinate eq. to Chromium USP 200 mcg
Biotin USP 5 mg
Excipients q.s.
Approved colour used in empty capsule shells
154 Itraconazole Capsules
Composition Standard Quantity
Each hard gelatin capsule contains :
Itraconazole (as pellets) I.P. 100 mg
Excipients q.s.
Approved colour used in empty capsule shells & pellets
155 Aspirin Gasto-resistant & Rosuvastatin Capsules I.P
Composition Standard Quantity
Each hard gelatin capsule contains :
Aspirin (as enteric coated pellets) I.P. 75 mg
Rosuvastatin Calcium eq. to Rosuvastatin (as pellets) I.P. 20 mg
Excipients q.s.
Approved Colour used in empty capsule shells & pellets
156 Metoprolol Succinate (ER) Tablets I.P.
Composition Standard Quantity
Each uncoated extended release tablet contains :
Metoprolol Succinate
(eq. to Metoprolol Tartrate, extended release)		 I.P. 25 mg
Excipients q.s.
Approved Colour used
157 Diclofenac Potassium Paracetamol and Serratiopeptidase Tablets (Warning: Overdose of this drug has potential of severe liver injury & allergic reactions (e.g. swelling of face, mouth & throat, difficulty in breathing, itching or rashes)
Composition Standard Quantity
Each film coated tablet contains :
Diclofenac Potassium B.P. 50 mg
Paracetamol I.P. 325 mg
Serratiopeptidase
(as enteric coated granules, eq. to enzymatic activity 20,000 units)		 I.P. 10 mg
Excipients q.s.
Approved Colour used
158 Glimepiride, Metformin HCl (SR) and Pioglitazone Tablets [Note: Package Insert as per H&FW Deptt. Notification No. GSR520(E) dated 31.07.2013 to to be enclosed]
Composition Standard Quantity
Each uncoated bilayered tablet contains :
Glimepiride I.P. 1 mg
Metformin Hydrochloride
(In sustained release form)		 I.P. 500 mg
Pioglitazone Hydrochloride
eq. to Pioglitazone		 I.P. 15 mg
Excipients q.s.
Approved Colour used
159 Itraconazole Capsules
Composition Standard Quantity
Each hard gelatin capsule contains :
Itraconazole (as pellets) I.P. 200 mg
Excipients q.s.
Approved Colour used in empty capsule shells
160 Mefenamic Acid Capsules I.P 250 mg
Composition Standard Quantity
Each hard gelatin capsule contains :
Mefenamic Acid I.P. 250 mg
Excipients q.s.
Approved colour used in empty capsule shells
161 Glimepiride, Metformin HCl (SR) and Pioglitazone Tablets [Note: Package Insert as per H&FW Deptt. Notification No. GSR520(E) dated 31.07.2013 to to be enclosed]
Composition Standard Quantity
Each uncoated bilayered tablet contains :
Glimepiride I.P. 2 mg
Metformin Hydrochloride
(In sustained release form)		 I.P. 500 mg
Pioglitazone Hydrochloride
eq. to Pioglitazone		 I.P. 15 mg
Excipients q.s.
Approved Colour used
162 Diclofenac Potassium and Serratiopeptidase Tablets
Composition Standard Quantity
Each enteric coated tablet contains :
Diclofenac Potassium B.P. 50 mg
Serratiopeptidase
(as enteric coated granules eq. to enzymatic activity 20,000 units)		 I.P. 10 mg
Excipients q.s.
Approved Colour used
163 Thiocolchicoside Capsules I.P 8 mg
Composition Standard Quantity
Each hard gelatin capsule contains :
Thiocolchicoside I.P. 8 mg
Excipients q.s.
Approved colour used in empty capsule shells
164 Thiocolchicoside Capsules I.P 4 mg
Composition Standard Quantity
Each hard gelatin capsule contains :
Thiocolchicoside I.P. 4 mg
Excipients q.s.
Approved colour used in empty capsule shells
165 Rabeprazole and Ondansetron Tablets
Composition Standard Quantity
Each enteric coated tablet contains :
Rabeprazole Sodium I.P. 20 mg
Ondansetron Hydrochloride
(eq. to Ondansetron)		 I.P. 4 mg
Excipients q.s.
Approved Colour used
166 Doxylamine Succinate, Pyridoxine HCl & Folic Acid Tablets
Composition Standard Quantity
Each enteric coated tablet contains :
Doxylamine Succinate USP 10 mg
Pyridoxine Hydrochloride I.P. 10 mg
Folic Acid I.P. 2.5 mg
Excipients q.s.
Approved Colour used
167 Clindamycin Hydrochloride Capsules
Composition Standard Quantity
Each hard gelatin capsule contains :
Clindamycin Hydrochloride eq. to Clindamycin I.P. 300 mg
Excipients q.s.
Approved colour used in empty capsule shells
168 Aceclofenac, Paracetamol, Cetirizine Dihydrochloride, Phenylephrine HCl and CaffeineTablets
Composition Standard Quantity
Each uncoated tablet contains :
Aceclofenac I.P. 100 mg
Paracetamol I.P. 325 mg
Cetirizine Dihydrochloride I.P. 10 mg
Phenylephrine Hydrochloride I.P. 5 mg
Caffeine I.P. 25 mg
Excipients q.s.
Approved Colour used
169 Rosuvastatin and Aspirin Capsules
Composition Standard Quantity
Each hard gelatin capsule contains :
Rosuvastatin Calcium eq. to Rosuvastatin (as pellets) I.P. 10 mg
Aspirin (as enteric coated pellets) I.P. 75 mg
Excipients q.s.
Approved colour used
170 Ferrous Ascorbate, Folic acid and Zinc Sulphate Monohydrate Tablets
Composition Standard Quantity
Each film coated tablet contains :
Ferrous Ascorbate I.P. 100 mg
Folic Acid I.P. 1.5 mg
Zinc Sulphate Monohydrate (eq. to Elemental Zinc) I.P. 22.5 mg
Excipients q.s.
Approved Colour used
171 Rosuvastatin and Aspirin Capsules
Composition Standard Quantity
Each hard gelatin capsule contains :
Rosuvastatin Calcium eq. to Rosuvastatin (as granules) I.P. 20 mg
Aspirin (as enteric coated tablets) I.P. 75 mg
Excipients q.s.
Approved colour used
172 Rosuvastatin and Aspirin Capsules
Composition Standard Quantity
Each hard gelatin capsule contains :
Rosuvastatin Calcium eq. to Rosuvastatin (as granules) I.P. 10 mg
Aspirin (as enteric coated tablets) I.P. 75 mg
Excipients q.s.
Approved colour used
173 Acebrophylline Sustained Release, Fexofenadine HCl and Montelukast Tablets
Composition Standard Quantity
Each film coated tablet contains :
Acebrophylline (as sustained release form) 200 mg
Fexofenadine Hydrochloride I.P. 120 mg
Montelukast Sodium (eq. to Montelukast) I.P. 10 mg
Excipients q.s.
Approved Colour used
174 Levocetirizine Dihydrochloride, Montelukast and Ambroxol HCl (SR) Tablets
Composition Standard Quantity
Each film coated tablet contains :
Levocetirizine Dihydrochloride I.P. 5 mg
Montelukast Sodium (eq. to Montelukast) I.P. 10 mg
Ambroxol Hydrochloride (as sustained release) I.P. 75 mg
Excipients q.s.
Approved Colour used
175 Naproxen and Domperidone Tablets
Composition Standard Quantity
Each film coated tablet contains :
Naproxen I.P. 500 mg
Domperidone I.P. 10 mg
Excipients q.s.
Approved Colour used
176 Doxycycline & Lactic Acid Bacillus Capsules
Composition Standard Quantity
Each hard gelatin capsule contains :
Doxycycline Hydrochloride eq. to Doxycycline I.P. 100 mg
Lactic Acid Bacillus 60 Million Spores
Excipients q.s.
Approved colour used in capsule shells
177 Rosuvastatin, Clopidogrel and Aspirin Capsules
Composition Standard Quantity
Each hard gelatin capsule contains :
Rosuvastatin Calcium eq. to Rosuvastatin (as pellets) I.P. 10 mg
Clopidogrel Bisulphate eq. to Clopidogrel (as pellets) I.P. 75 mg
Aspirin (as enteric coated pellets) I.P. 75 mg
Excipients q.s.
Approved colour used
178 Rabeprazole Sodium(EC) and Aceclofenac (SR) Capsules
Composition Standard Quantity
Each hard gelatin capsule contains :
Rabeprazole Sodium (as enteric coated pellets) I.P. 20 mg
Aceclofenac (as sustained release pellets) I.P. 200 mg
Excipients q.s.
Approved colour used in empty capsule shells
179 Esomeprazole (EC) and Itopride HCl (SR) Capsules
Composition Standard Quantity
Each hard gelatin capsule contains :
Esomeprazole Magnesium Trihydrate eq. to Esomeprazole (as enteric coated pellets) I.P. 40 mg
Itopride Hydrochloride (as sustained released pellets) I.P. 150 mg
Excipients q.s.
Approved colour used in empty capsule shells
180 Omeprazole Gastro-resistant Capsules I.P.
Composition Standard Quantity
Each hard gelatin capsule contains :
Omeprazole (as gastro resistant pellets) I.P. 20 mg
Excipients q.s.
Approved colour used in capsule shells
181 Teneligliptin and Metformin Hydrochloride (ER)Tablets
Composition Standard Quantity
Each uncoated bilayered tablet contains :
Teneligliptin Hydrobromide Hydrate (eq. to Teneligliptin) I.P. 20 mg
Metformin Hydrochloride (as extended release) I.P. 500 mg
Excipients q.s.
Approved Colour used
182 Methylcobalamin, Alpha Lipoic Acid, Benfotiamine, Pyridoxine HCl, Inositol and Folic Acid Capsules
Composition Standard Quantity
Each hard gelatin capsule contains :
Methylcobalamin I.P. 1000 mcg
Alpha Lipoic Acid I.P. 200 mg
Benfotiamine 100 mg
Folic Acid I.P. 1.5 mg
Pyridoxine HCl I.P. 3 mg
Inositol USP 100 mg
Excipients q.s.
Approved colour used in empty capsule shells
183 Methylcobalamin, Alpha Lipoic Acid, Benfotiamine, Pyridoxine HCl, Inositol and Folic Acid Capsules
Composition Standard Quantity
Each hard gelatin capsule contains :
Methylcobalamin I.P. 1000 mcg
Alpha Lipoic Acid I.P. 200 mg
Benfotiamine 100 mg
Folic Acid I.P. 1.5 mg
Pyridoxine HCl I.P. 3 mg
Inositol USP 100 mg
Excipients q.s.
Approved colour used in empty capsule shells
184 Methylcobalamin, Alpha Lipoic Acid, Thiamine Mononitrate, Pyridoxine Hydrochloride, and Folic Acid Capsules
Composition Standard Quantity
Each hard gelatin capsule contains :
Methylcobalamin I.P. 1500 mcg
Alpha Lipoic Acid I.P. 100 mg
Thiamine Mononitrate I.P. 10 mg
Pyridoxine Hydrochloride I.P. 3 mg
Folic Acid I.P. 1.5 mg
Excipients q.s.
Appropriate overages of vitamins are added to compensate loss on storage
Approved colour used in empty capsule shells
185 Paracetamol, Phenylephrine HCl and Cetirizine HCl Tablets
Composition Standard Quantity
Each uncoated tablet contains :
Paracetamol I.P. 325 mg
Phenylephrine Hydrochloride I.P. 5 mg
Cetirizine Hydrochloride I.P. 5 mg
Excipients q.s.
Approved Colour used
186 Pregabalin and Methylcobalamin Capsules I.P
Composition Standard Quantity
Each hard gelatin capsule contains :
Pregabalin I.P. 75 mg
Methylcobalamin I.P. 750 mcg
Excipients q.s.
Approved colour used in empty capsule shells
Appropriate overages of vitamin added to compensate loss on storage
187 Flupentixol and Melitracen Tablets
Composition Standard Quantity
Each film coated tablet contains :
Flupentixol Hydrochloride (Eq. to Flupentixol) B.P. 0.5 mg
Melitracen Hydrochloride (Eq. to Melitracen) 10 mg
Excipients q.s.
Approved Colour used
188 Esomeprazole and Levosulpride Capsules
Composition Standard Quantity
Each hard gelatin capsule contains :
Esomeprazole Magnesium Trihydrate eq. to Esomeprazole (as enteric coated pellets) I.P. 40 mg
Levosulpiride (as sustained released pellets) 75 mg
Excipients q.s.
Approved colour used in empty capsule shells
189 Sitagliptin Phosphate and Metformin Hydrochloride Tablets
Composition Standard Quantity
Each film coated tablet contains :
Sitagliptin Phosphate Monohydrate (Eq. to Sitagliptin) I.P. 50 mg
Metformin Hydrochloride I.P. 500 mg
Excipients q.s.
Approved Colour used
190 Pantoprazole and Levosulpiride Capsules
Composition Standard Quantity
Each hard gelatin capsule contains :
Pantoprazole Sodium eq. to Pantoprazole (as enteric coated pellets) I.P. 40
Levosulpiride (as sustained released pellets) 75
Excipients
Approved colour used in empty capsule shells
191 Fexofenadine and Montelukast Chewable Tablets
Composition Standard Quantity
Each uncoated chewable tablet contains :
Fexofenadine Hydrochloride I.P. 120 mg
Montelukast Sodium (eq. to Montelukast) I.P. 10 mg
Excipients q.s.
Approved Colour used
192 Levetiracetam Tablets I.P
Composition Standard Quantity
Each film coated tablet contains :
Levetiracetam I.P. 500 mg
Excipients q.s.
Approved Colour used
193 Rebeprazole and Itopride Hydrochloride Capsules
Composition Standard Quantity
Each hard gelatin capsule contains :
Rabeprazole Sodium (as enteric coated pellets) I.P. 20 mg
Itopride Hydrochloride (as sustained released pellets) 150 mg
Excipients q.s.
Approved colour used in empty capsule shells
194 Esomeprazole and Domperidone Capsules
Composition Standard Quantity
Each hard gelatin capsule contains :
Esomeprazole Magnesium Trihydrate eq. to Esomeprazole (as enteric coated pellets) I.P. 40 mg
Domperidone (as sustained released pellets) I.P. 30 mg
Excipients q.s.
Approved colour used in empty capsule shells
195 Tamsulosin HCl (MR) and Dutasteride Tablets
Composition Standard Quantity
Each film coated tablet contains :
Tamsulosin Hydrochloride (as modified release) I.P. 0.4 mg
Dutasteride I.P. 0.5 mg
Excipients q.s.
Approved Colour used
196 Rabeprazole and Levosulpride Capsules
Composition Standard Quantity
Each hard gelatin capsule contains :
Rabeprazole Sodium (as enteric coated pellets) I.P. 20 mg
Levosulpiride (as sustained released pellets) 75 mg
Excipients q.s.
Approved colour used in empty capsule shells
197 Pantoprazole Gasto-resistant and Domperidone Prolonged-release Capsules I.P
Composition Standard Quantity
Each hard gelatin capsule contains :
Pantoprazole Sodium eq. to Pantoprazole (as gastro-resistant pellets) I.P. 40 mg
Domperidone (as prolonged-release pellets) I.P. 30 mg
Excipients q.s.
Approved colour used in empty capsule shells
198 Rabeprazole and Domperidone Capsule
Composition Standard Quantity
Each hard gelatin capsule contains :
Rabeprazole Sodium (as enteric coated pellets) I.P. 20 mg
Domperidone (as sustained released pellets) I.P. 30 mg
Excipients q.s.
Approved colour used in empty capsule shells
199 Omeprazole and Domperidone Capsules I.P
Composition Standard Quantity
Each hard gelatin capsule contains :
Omeprazole (as enteric coated pellets) I.P. 20 mg
Domperidone I.P. 10 mg
Excipients q.s.
Approved colour used in empty capsule shells
200 Methylcobalamin, Alpha Lipoic Acid, Inositol, Folic Acid, Chromium Polynicotinate, Selenium Dioxide and Benfotiamine Capsules
Composition Standard Quantity
Each hard gelatin capsule contains :
Methylcobalamin I.P. 1500 mcg
Alpha Lipoic Acid USP 100 mg
Inositol USP 100 mg
Folic Acid I.P. 1.5 mg
Chromium Polynicotinate USP 200 mcg
Selenium Dioxide B.P. 55 mcg
Benfotiamine USP 150 mg
Excipients q.s.
Approved colour used in empty capsule shells
201 Vildagliptin and Metformin Hydrochloride Tablets
Composition Standard Quantity
Each film coated tablet contains :
Vildagliptin I.P. 50 mg
Metformin Hydrochloride I.P. 1000 mg
Excipients q.s.
Approved Colour used
202 Vildagliptin and Metformin Hydrochloride Tablets
Composition Standard Quantity
Each film coated tablet contains :
Vildagliptin I.P. 50 mg
Metformin Hydrochloride I.P. 850 mg
Excipients q.s.
Approved Colour used
203 Vildagliptin and Metformin Hydrochloride Tablets
Composition Standard Quantity
Each film coated tablet contains :
Vildagliptin I.P. 50 mg
Metformin Hydrochloride I.P. 500 mg
Excipients q.s.
Approved Colour used
204 Metformin HCl Prolonged release and Glimepiride Tablets I.P
Composition Standard Quantity
Each uncoated bilayered tablet contains :
Metformin Hydrochloride (In Prolonged release form) I.P. 500 mg
Glimepiride I.P. 2 mg
Excipients q.s.
Approved Colour used
205 Metformin HCl Prolonged release and Glimepiride Tablets I.P
Composition Standard Quantity
Each uncoated bilayered tablet contains :
Metformin Hydrochloride (In Prolonged release form) I.P. 500 mg
Glimepiride I.P. 1 mg
Excipients q.s.
Approved Colour used
206 Citicoline and Piracetam Tablets
Composition Standard Quantity
Each film coated tablet contains :
Citicoline Sodium (eq. to Citicoline) I.P. 500 mg
Piracetam I.P. 400 mg
Excipients q.s.
Approved Colour used
207 Drotaverine Hydrochloride and Mefenamic Acid Tablets
Composition Standard Quantity
Each film coated tablet contains :
Drotaverine Hydrochloride I.P. 80 mg
Mefenamic Acid I.P. 250 mg
Excipients q.s.
Approved Colour used
208 Trypsin,Bromelain, Rustoside Trihydrate and Aceclofenac Tablets
Composition Standard Quantity
Each enteric coated tablet contains :
Trypsin B.P. 48 mg
Bromelain 90 mg
Rustoside Trihydrate B.P. 100 mg
Aceclofenac I.P. 100 mg
Excipients q.s.
Approved Colour used
209 Glimepiride and Metformin Hydrochloride (SR) Tablets
Composition Standard Quantity
Each uncoated bilayered tablet contains :
Glimepiride I.P. 2 mg
Metformin Hydrochloride (sustained released) I.P. 1000 mg
Excipients q.s.
Approved Colour used
210 Diclofenac Potassium Paracetamol and Chlorzoxazone Tablets (Warning: Overdose of this drug has potential of severe liver injury & allergic reactions (e.g. swelling of face, mouth & throat, difficulty in breathing, itching or rashes)
Composition Standard Quantity
Each film coated tablet contains :
Diclofenac Potassium B.P. 50 mg
Paracetamol I.P. 325 mg
Chlorzoxazone USP 250 mg
Excipients q.s.
Approved Colour used
211 Gabapentin & Nortriptyline HCl Tablets
Composition Standard Quantity
Each film coated tablet contains :
Gabapentin I.P. 400 mg
Nortriptyline Hydrochloride (Eq. to Nortriptyline) I.P. 10 mg
Excipients q.s.
Approved Colour used
212 Ketorolac Tromethamine Dispersible Tablets 10mg
Composition Standard Quantity
Each uncoated dispersible tablet contains :
Ketorolac Tromethamine I.P. 10 mg
Excipients q.s.
Approved Colour used
213 Rabeprazole and Domperidone Tablets
Composition Standard Quantity
Each enteric coated tablet contains :
Rabeprazole Sodium I.P. 20 mg
Domperidone I.P. 10 mg
Excipients q.s.
Approved Colour used
214 Amisulpiride Tablets IP 50 mg
Composition Standard Quantity
Each film coated tablet contains :
Amisulpride I.P. 50 mg
Excipients q.s.
Approved colour used
215 Sildenafil Citrate Tablets I.P. 50 mg
Composition Standard Quantity
Each film-coated tablet contains :
Sildenafil Citrate (eq. to Sildenafil) I.P. 50 mg
Excipients q.s.
Approved Colour used
216 Tolperisone HCl and Diclofenac Sodium Tablets
Composition Standard Quantity
Each uncoated tablet contains :
Tolperisone Hydrochloride 150 mg
Diclofenac Sodium I.P. 50 mg
Excipients q.s.
Approved Colour used
217 Cinnarizine and Domperidone Tablets
Composition Standard Quantity
Each uncoated tablet contains :
Cinnarizine I.P. 20 mg
Domperidone I.P. 15 mg
Excipients q.s.
Approved Colour used
218 Eperisone Hydrochloride and Paracetamol Tablets
Composition Standard Quantity
Each film coated tablet contains :
Eperisone Hydrochloride 50 mg
Paracetamol I.P. 325 mg
Excipients q.s.
Approved Colour used
219 Levosulpride Tablets
Composition Standard Quantity
Each film coated tablet contains :
Levosulpiride 50 mg
Excipients q.s.
Approved Colour used
220 Terbinafine Tablets I.P 250 mg
Composition Standard Quantity
Each uncoated tablet contains :
Terbinafine Hydrochloride (eq. to Terbinafine) I.P. 250 mg
Excipients q.s.
Approved Colour used
221 Trypsin,Bromelain, Rustoside Trihydrate and Diclofenac Sodium Tablets
Composition Standard Quantity
Each enteric coated tablet contains :
Trypsin B.P. 48 mg
Bromelain 90 mg
Rutoside Trihydrate B.P. 100 mg
Diclofenac Sodium I.P. 50 mg
Excipients q.s.
Approved Colour used
222 Trypsin,Bromelain and Rustoside Trihydrate Tablets
Composition Standard Quantity
Each enteric coated tablet contains :
Trypsin B.P. 48 mg
Bromelain 90 mg
Rutoside Trihydrate B.P. 100 mg
Excipients q.s.
Approved Colour used
223 Aceclofenac and Thiocolchicoside Tablets
Composition Standard Quantity
Each film coated tablet contains :
Aceclofenac I.P. 100 mg
Thiocolchicoside I.P. 8 mg
Excipients q.s.
Approved Colour used
224 Levocetirizine Hydrochloride and Ambroxol Hydrochloride (SR) Tablets
Composition Standard Quantity
Each uncoated sustained released tablet contains :
Levocetirizine Hydrochloride I.P. 5 mg
Ambroxol Hydrochloride (as sustained released) I.P. 75 mg
Excipients q.s.
Approved Colour used
225 Tranexamic Acid and Mefenamic Acid Tablets
Composition Standard Quantity
Each film coated tablet contains :
Tranexamic Acid I.P. 500 mg
Mefenamic Acid I.P. 250 mg
Excipients q.s.
Approved Colour used
226 Etoricoxib and Paracetamol Tablets
Composition Standard Quantity
Each film coated tablet contains :
Etoricoxib I.P. 60 mg
Paracetamol I.P. 325 mg
Excipients q.s.
Approved Colour used
227 Diclofenac Sodium and Serratiopeptidase Tablets
Composition Standard Quantity
Each enteric coated tablet contains :
Diclofenac Sodium B.P. 50 mg
Serratiopeptidase (as enteric coated granules, eq. to enzymatic activity 20,000 units) I.P. 10 mg
Excipients q.s.
Approved Colour used
228 Glucosamine, Methylsulphonylmethane and Diacerein Tablets
Composition Standard Quantity
Each film coated tablet contains :
Glucosamine Sulphate Potassium Chloride (eq. to Glucosamine) USP 446 mg (750 mg eq.)
Methylsulphonylmethane USP 250 mg
Diacerein I.P. 50 mg
Excipients q.s.
Approved Colour used
229 Montelukast and Levocetirizine Hydrochloride Tablets I.P
Composition Standard Quantity
Each film coated tablet contains :
Levocetirizine Hydrochloride I.P. 2.5 mg
Montelukast Sodium (eq. to Montelukast) I.P. 4 mg
Excipients q.s.
Approved Colour used
230 Aceclofenac Sustained Released Tablets 200mg
Composition Standard Quantity
Each uncoated sustained released tablet contains :
Aceclofenac I.P. 200 mg
Excipients q.s.
Approved Colour used
231 Lornoxicam and Paracetamol Tablets
Composition Standard Quantity
Each film coated tablet contains :
Lornoxicam 8 mg
Paracetamol I.P. 325 mg
Excipients q.s.
Approved Colour used
232 Lornoxicam and Paracetamol Tablets
Composition Standard Quantity
Each film coated tablet contains :
Lornoxicam 4 mg
Paracetamol I.P. 325 mg
Excipients q.s.
Approved Colour used
233 Metoprolol Succinate (ER) Tablets I.P.
Composition Standard Quantity
Each film coated tablet contains :
Metoprolol Succinate (eq. to Metoprolol Tartrate, extended released) I.P. 47.50 mg (50 mg eq.)
Excipients q.s.
Approved Colour used
234 Metoprolol Succinate (ER) Tablets I.P.
Composition Standard Quantity
Each film coated tablet contains :
Metoprolol Succinate (eq. to Metoprolol Tartrate, extended released) I.P. 23.75 mg (25 mg eq.)
Excipients q.s.
Approved Colour used
235 Mefenamic Acid and Dicyclomine HCl Tablets I.P
Composition Standard Quantity
Each uncoated tablet contains :
Mefenamic Acid I.P. 250 mg
Dicyclomine Hydrochloride I.P. 10 mg
Excipients q.s.
Approved Colour used
236 Diclofenac Sodium and Paracetamol Tablets I.P (Warning: Overdose of this drug has potential of severe liver injury & allergic reactions (e.g. swelling of face, mouth & throat, difficulty in breathing, itching or rashes)
Composition Standard Quantity
Each uncoated tablet contains :
Diclofenac Sodium I.P. 50 mg
Paracetamol I.P. 325 mg
Excipients q.s.
237 Amlodipine Besylate and Metoprolol Succinate (ER)Tablets
Composition Standard Quantity
Each uncoated tablet contains :
Amlodipine Besylate (Eq. to Amlodipine) I.P. 5 mg
Metoprolol Succinate (eq. to Metoprolol Tartrate, Extended Released) I.P. 47.5 mg (50 mg eq.)
Excipients q.s.
Approved Colour used
238 Amlodipine Besilate and Atenolol Tablets I.P.
Composition Standard Quantity
Each uncoated tablet contains :
Amlodipine Besilate (eq. to Amlodipine) I.P. 5 mg
Atenolol I.P. 50 mg
Excipients q.s.
Approved Colour used
239 Amlodipine Besilate Tablets I.P.
Composition Standard Quantity
Each film coated tablet contains :
Amlodipine Besilate (eq. to Amlodipine) I.P. 5 mg
Excipients q.s.
Approved Colour used
240 Metformin Hydrochloride Sustained Released Tablets I.P.
Composition Standard Quantity
Each uncoated tablet contains :
Metformin Hydrochloride (sustained released) I.P. 500 mg
Excipients q.s.
Approved Colour used
241 Losartan Potassium and Hydrochlorothiazide Tablets I.P.
Composition Standard Quantity
Each film coated tablet contains :
Losartan Potassium I.P. 50 mg
Hydrochlorothiazide I.P. 12.5 mg
Excipients q.s.
Approved Colour used
242 Losartan Potassium and Amlodipine Tablets I.P.
Composition Standard Quantity
Each film coated tablet contains :
Losartan Potassium I.P. 50 mg
Excipients q.s.
Approved Colour used
243 Losartan Potassium Tablets I.P. 50 mg
Composition Standard Quantity
Each film coated tablet contains :
Losartan Potassium I.P. 50 mg
Excipients q.s.
Approved Colour used
244 Linezolid Tablets I.P.
Composition Standard Quantity
Each film coated tablet contains :
Linezolid I.P. 600 mg
Excipients q.s.
Approved Colour used
245 Olmesartan Medoxomil and Amlodipine Tablets
Composition Standard Quantity
Each uncoated tablet contains :
Olmesartan Medoxomil I.P. 40 mg
Amlodipine Besylate (eq. to Amlodipine) I.P. 5 mg
Excipients q.s.
Approved Colour used
246 Olmesartan Medoxomil 20 mg and Hydrochlorothiazide 12.5 mg Tablets I.P
Composition Standard Quantity
Each uncoated tablet contains :
Olmesartan Medoxomil I.P. 20 mg
Hydrochlorothiazide I.P. 12.5 mg
Excipients q.s.
Approved Colour used
247 Olmesartan Medoxomil Tablets I.P. 40 mg
Composition Standard Quantity
Each film coated tablet contains :
Olmesartan Medoxomil I.P. 40 mg
Excipients q.s.
Approved Colour used
248 Olmesartan Medoxomil Tablets I.P. 20 mg
Composition Standard Quantity
Each film coated tablet contains :
Olmesartan Medoxomil I.P. 20 mg
Excipients q.s.
Approved Colour used
249 Loratadine Tablets I.P.
Composition Standard Quantity
Each uncoated tablet contains :
Loratadine I.P. 10 mg
Excipients q.s.
Approved Colour used
250 Citicoline Tablets I.P 500 mg
Composition Standard Quantity
Each film coated tablet contains :
Citicoline Sodium (eq. to Citicoline) I.P. 500 mg
Excipients q.s.
Approved Colour used
251 Hydroxyzine Tablets I.P. 25 mg
Composition Standard Quantity
Each uncoated tablet contains :
Hydroxyzine Hydrochloride I.P. 25 mg
Excipients q.s.
Approved Colour used
252 Hydroxyzine Tablets I.P. 10 mg
Composition Standard Quantity
Each uncoated tablet contains :
Hydroxyzine Hydrochloride I.P. 10 mg
Excipients q.s.
Approved Colour used
253 Voglibose Tablets I.P. 0.3 mg
Composition Standard Quantity
Each uncoated tablet contains :
Voglibose I.P. 0.3 mg
Excipients q.s.
Approved Colour used
254 Voglibose Tablets I.P. 0.2 mg
Composition Standard Quantity
Each uncoated tablet contains :
Voglibose I.P. 0.2 mg
Excipients q.s.
Approved Colour used
255 Febuxostat Tablets 80 mg
Composition Standard Quantity
Each film coated tablet contains :
Febuxostat 80 mg
Excipients q.s.
Approved Colour used
256 Febuxostat Tablets 40 mg
Composition Standard Quantity
Each film coated tablet contains :
Febuxostat 40 mg
Excipients q.s.
Approved Colour used
257 Serratiopeptidase Tablets I.P. 10 mg
Composition Standard Quantity
Each enteric coated tablet contains :
Serratiopeptidase (as enteric coated granules eq. to enzymatic activity 20,000 units) I.P. 10 mg
Excipients q.s.
Approved Colour used
258 Paracetamol Tablets I.P. 650 mg
Composition Standard Quantity
Each uncoated tablet contains :
Paracetamol I.P. 650 mg
Excipients q.s.
Approved Colour used
259 Betahistine Hydrochloride Tablets I.P.
Composition Standard Quantity
Each film coated tablet contains :
Betahistine Hydrochloride I.P. 8 mg
Excipients q.s.
Approved Colour used
260 Betahistine Hydrochloride Tablets I.P.
Composition Standard Quantity
Each film coated tablet contains :
Betahistine Hydrochloride I.P. 16 mg
Excipients q.s.
Approved Colour used
261 Levocetirizine Tablets I.P. 5 mg
Composition Standard Quantity
Each uncoated tablet contains :
Levocetirizine Hydrochloride I.P. 5 mg
Excipients q.s.
Approved Colour used
262 Cetirizine Hydrochloride Tablets I.P. 10 mg
Composition Standard Quantity
Each uncoated tablet contains :
Cetirizine Hydrochloride I.P. 10 mg
Excipients q.s.
Approved Colour used
263 Pantoprazole Gastro-resistant Tablets I.P. 40 mg
Composition Standard Quantity
Each enteric-coated tablet contains :
Pantoprazole Sodium eq. to Pantoprazole I.P. 40 mg
Excipients q.s.
Approved Colour used
264 Divalproex Extended Release Tablets I.P 1000mg
Composition Standard Quantity
Each film-coated extended-release tablet contains :
Divalproex Sodium eq. to Valproic Acid I.P. 1000 mg
Excipients q.s.
Approved Colour used
265 Divalproex Extended Release Tablets I.P 500mg
Composition Standard Quantity
Each film-coated extended-release tablet contains :
Divalproex Sodium eq. to Valproic Acid I.P. 500 mg
Excipients q.s.
Approved Colour used
266 Divalproex Extended Release Tablets I.P 250mg
Composition Standard Quantity
Each film-coated extended-release tablet contains :
Divalproex Sodium eq. to Valproic Acid I.P. 250 mg
Excipients q.s.
Approved Colour used
267 Telmisartan, Amlodipine and Hydrochlorothiazide Tablets
Composition Standard Quantity
Each uncoated tablet contains :
Telmisartan I.P. 40 mg
Amlodipine Besylate eq. to Amlodipine I.P. 5 mg
Hydrochlorothiazide I.P. 12.5 mg
Excipients q.s.
Approved Colour used
268 Telmisartan 80 mg and Hydrochlorothiazide 12.5 mg Tablets I.P
Composition Standard Quantity
Each film-coated tablet contains :
Telmisartan I.P. 80 mg
Hydrochlorothiazide I.P. 12.5 mg
Excipients q.s.
Approved Colour used
269 Telmisartan 40 mg and Hydrochlorothiazide 12.5 mg Tablets I.P.
Composition Standard Quantity
Each film-coated tablet contains :
Telmisartan I.P. 40 mg
Hydrochlorothiazide I.P. 12.5 mg
Excipients q.s.
Approved Colour used
270 Telmisartan Tablets I.P. 80 mg
Composition Standard Quantity
Each uncoated tablet contains :
Telmisartan I.P. 80 mg
Excipients q.s.
Approved Colour used
271 Telmisartan Tablets I.P. 40 mg
Composition Standard Quantity
Each uncoated tablet contains :
Telmisartan I.P. 40 mg
Excipients q.s.
Approved Colour used
272 Telmisartan Tablets I.P. 20 mg
Composition Standard Quantity
Each uncoated tablet contains :
Telmisartan I.P. 20 mg
Excipients q.s.
Approved Colour used
273 Duloxetine Hydrochloride Tablets 30 mg
Composition Standard Quantity
Each enteric-coated tablet contains :
Duloxetine Hydrochloride eq. to Duloxetine I.P. 30 mg
Excipients q.s.
Approved Colour used
274 Duloxetine Hydrochloride Tablets 20mg
Composition Standard Quantity
Each enteric-coated tablet contains :
Duloxetine Hydrochloride eq. to Duloxetine I.P. 20 mg
Excipients q.s.
Approved Colour used
275 Rosuvastatin Calcium and Fenofibrate Tablets
Composition Standard Quantity
Each film-coated tablet contains :
Rosuvastatin Calcium eq. to Rosuvastatin I.P. 10 mg
Fenofibrate I.P. 160 mg
Excipients q.s.
Colour
276 Rosuvastatin Calcium Tablets I.P. 20 mg
Composition Standard Quantity
Each film-coated tablet contains :
Rosuvastatin Calcium eq. to Rosuvastatin I.P. 20 mg
Excipients q.s.
Approved Colour used
277 Rosuvastatin Calcium Tablets I.P. 10 mg
Composition Standard Quantity
Each film-coated tablet contains :
Rosuvastatin Calcium eq. to Rosuvastatin I.P. 10 mg
Excipients q.s.
Approved Colour used
278 Rosuvastatin Calcium Tablets I.P. 5 mg
Composition Standard Quantity
Each film-coated tablet contains :
Rosuvastatin Calcium eq. to Rosuvastatin I.P. 5 mg
Excipients q.s.
Approved Colour used
279 Methylprednisolone Tablets I.P. 16 mg
Composition Standard Quantity
Each uncoated tablet contains :
Methylprednisolone I.P. 16 mg
Excipients q.s.
Approved Colour used
280 Methylprednisolone Tablets 8 mg
Composition Standard Quantity
Each uncoated tablet contains :
Methylprednisolone I.P. 8 mg
Excipients q.s.
Approved Colour used
281 Methylprednisolone Tablets I.P. 4 mg
Composition Standard Quantity
Each uncoated tablet contains :
Methylprednisolone I.P. 4 mg
Excipients q.s.
Approved Colour used
282 Atenolol Tablets I.P. 100 mg
Composition Standard Quantity
Each uncoated tablet contains :
Atenolol I.P. 100 mg
Excipients q.s.
Approved Colour used
283 Atenolol Tablets I.P. 50 mg
Composition Standard Quantity
Each uncoated tablet contains :
Atenolol I.P. 50 mg
Excipients q.s.
Approved Colour used
284 Atorvastatin Calcium and Fenofibrate Tablets
Composition Standard Quantity
Each film-coated tablet contains :
Atorvastatin Calcium eq. to Atorvastatin I.P. 10 mg
Fenofibrate I.P. 160 mg
Excipients q.s.
Approved Colour used
285 Atorvastatin Tablets I.P. 40 mg
Composition Standard Quantity
Each film-coated tablet contains :
Atorvastatin Calcium eq. to Atorvastatin I.P. 40 mg
Excipients q.s.
Approved Colour used
286 Atorvastatin Tablets I.P. 20 mg
Composition Standard Quantity
Each film-coated tablet contains :
Atorvastatin Calcium eq. to Atorvastatin I.P. 20 mg
Excipients q.s.
Approved Colour used
287 Atorvastatin Tablets I.P. 10 mg
Composition Standard Quantity
Each film-coated tablet contains :
Atorvastatin Calcium eq. to Atorvastatin I.P. 10 mg
Excipients q.s.
Approved Colour used
288 Fexofenadine and Montelukast Tablets
Composition Standard Quantity
Each chewable film-coated tablet contains :
Fexofenadine Hydrochloride I.P. 120 mg
Montelukast Sodium eq. to Montelukast I.P. 10 mg
Excipients q.s.
Approved Colour used
289 Fexofenadine Hydrochloride Tablets I.P. 180 mg
Composition Standard Quantity
Each film-coated tablet contains :
Fexofenadine Hydrochloride I.P. 180 mg
Excipients q.s.
Approved Colour used
290 Fexofenadine Hydrochloride Tablets I.P. 120 mg
Composition Standard Quantity
Each film-coated tablet contains :
Fexofenadine Hydrochloride I.P. 120 mg
Excipients q.s.
Approved Colour used
291 Escitalopram Tablets I.P 20 mg
Composition Standard Quantity
Each film-coated tablet contains :
Escitalopram Oxalate eq. to Escitalopram I.P. 20 mg
Excipients q.s.
Approved Colour used
292 Escitalopram Tablets I.P 10 mg
Composition Standard Quantity
Each film-coated tablet contains :
Escitalopram Oxalate eq. to Escitalopram I.P. 10 mg
Excipients q.s.
Approved Colour used
293 Escitalopram Tablets I.P 5 mg
Composition Standard Quantity
Each film coated tablet contains :
Escitalopram Oxalate
(eq. to Escitalopram)		 I.P. 5 mg
Excipients — q.s.
Approved Colour used — —
294 Etoricoxib Tablets I.P 120 mg
Composition Standard Quantity
Each film coated tablet contains :
Etoricoxib I.P. 120 mg
Excipients — q.s.
Approved Colour used — —
295 Etoricoxib Tablets I.P 90 mg
Composition Standard Quantity
Each film coated tablet contains :
Etoricoxib I.P. 90 mg
Excipients — q.s.
Approved Colour used — —
296 Etoricoxib Tablets I.P 60 mg
Composition Standard Quantity
Each film-coated tablet contains :
Etoricoxib I.P. 60 mg
Excipients — q.s.
Approved Colour used — —
297 Ondansetron Orally Disintegrating Tablets I.P. 8 mg
Composition Standard Quantity
Each uncoated tablet contains :
Ondansetron Hydrochloride
(eq. to Ondansetron)		 I.P. 8 mg
Excipients — q.s.
Approved Colour used — —
298 Ondansetron Orally Disintegrating Tablets I.P. 4 mg
Composition Standard Quantity
Each uncoated tablet contains :
Ondansetron Hydrochloride
(eq. to Ondansetron)		 I.P. 4 mg
Excipients — q.s.
Approved Colour used — —
299 Sildenafil Citrate Tablets I.P. 100 mg
Composition Standard Quantity
Each film-coated tablet contains :
Sildenafil Citrate
(eq. to Sildenafil)		 I.P. 100 mg
Excipients — q.s.
Approved Colour used — —
300 Paracetamol and Nimesulide Tablets (Not to be used for children below 12 years of age)
Composition Standard Quantity
Each uncoated tablet contains :
Paracetamol I.P. 325 mg
Nimesulide B.P. 100 mg
Excipients — q.s.
Approved Colour used — —
301 Roxithromycin Tablets I.P. 150 mg
Composition Standard Quantity
Each film coated tablet contains :
Roxithromycin I.P. 150 mg
Excipients — q.s.
Approved Colour used — —
302 Deflazacort Tablets
Composition Standard Quantity
Each uncoated tablet contains :
Deflazacort — 30 mg
Excipients — q.s.
Approved Colour used — —
303 Deflazacort Tablets
Composition Standard Quantity
Each uncoated tablet contains :
Deflazacort — 6 mg
Excipients — q.s.
Approved Colour used — —
304 Rabeprazole Gastro-resistant Tablets I.P. 20mg
Composition Standard Quantity
Each enteric coated tablet contains :
Rabeprazole Sodium I.P. 20 mg
Excipients — q.s.
Approved Colour used — —
305 Ofloxacin & Ornidazole Tablets I.P
Composition Standard Quantity
Each film coated tablet contains :
Ofloxacin I.P. 200 mg
Ornidazole I.P. 500 mg
Excipients — q.s.
Approved Colour used — —
306 Levofloxacin Tablets I.P. 750 mg
Composition Standard Quantity
Each film coated tablet contains:
Levofloxacin Hemihydrate
(eq. to Levofloxacin)		 I.P. 750 mg
Excipients — q.s.
Approved Colour used — —
307 Levofloxacin Tablets I.P. 500 mg
Composition Standard Quantity
Each film coated tablet contains:
Levofloxacin Hemihydrate
(eq. to Levofloxacin)		 I.P. 500 mg
Excipients — q.s.
Approved Colour used — —
308 Levofloxacin Tablets I.P. 250 mg
Composition Standard Quantity
Each film coated tablet contains:
Levofloxacin Hemihydrate
(eq. to Levofloxacin)		 I.P. 250 mg
Excipients — q.s.
Approved Colour used — —
309 Pregabalin, Nortriptyline & Mecobalamin Tablets
Composition Standard Quantity
Each film coated tablet contains:
Pregabalin I.P. 75 mg
Nortriptyline Hydrochloride
(Eq. to Nortriptyline)		 I.P. 10 mg
Mecobalamin I.P. 1500 mcg
Excipients — q.s.
Approved Colour used — —
310 Azithromycin & Lactic Acid Bacillus Tablets
Composition Standard Quantity
Each film coated tablet contains:
Azithromycin Dihydrate
(eq. to Azithromycin anhydrous)		 I.P. 500 mg
Lactic Acid Bacillus — 60 Million Spores
Excipients — q.s.
Approved Colour used — —
311 Ferrous Ascorbate, Cyanocobalamin, Folic Acid, Zinc Sulphate Monohydrate Tablets
Composition Standard Quantity
Each film coated tablet contains:
Ferrous Ascorbate — 100 mg
Cyanocobalamin I.P. 15 mcg
Folic Acid I.P. 1.5 mg
Zinc Sulphate Monohydrate
(eq. to Elemental Zinc)		 I.P. 22.5 mg
Excipients — q.s.
Approved Colour used — —
312 Ofloxacin Tablets I.P.
Composition Standard Quantity
Each film coated tablet contains:
Ofloxacin I.P. 200 mg
Excipients — q.s.
Approved Colour used — —
313 Pregabalin (SR) and Methylcobalamin Tablets
Composition Standard Quantity
Each uncoated tablet contains:
Pregabalin (Sustained Release) I.P. 75 mg
Methylcobalamin I.P. 1500 mcg
Excipients — q.s.
Approved Colour used — —
314 Calcium Citrate, Zinc,Vitamin D3 and Magnesium Tablets
Composition Standard Quantity
Each uncoated tablet contains:
Calcium Citrate USP 1000 mg
Zinc Sulphate Monohydrate
eq. to Elemental Zinc		 I.P. 4 mg
Vitamin D3 I.P. 200 IU
Magnesium Hydroxide
eq. to Elemental Magnesium		 I.P. 100 mg
Excipients — q.s.
Approved Colour used — —
315 Gabapentin and Methylcobalamin Tablets
Composition Standard Quantity
Each film coated tablet contains:
Gabapentin I.P. 300 mg
Methylcobalamin I.P. 500 mcg
Excipients — q.s.
Approved Colour used — —
316 Azithromycin Tablets I.P.
Composition Standard Quantity
Each film coated tablet contains:
Azithromycin Dihydrate
(eq. to Azithromycin Anhydrous)		 I.P. 500 mg
Excipients — q.s.
Approved Colour used — —
317 Azithromycin Tablets I.P.
Composition Standard Quantity
Each film coated tablet contains:
Azithromycin Dihydrate
(eq. to Azithromycin Anhydrous)		 I.P. 250 mg
Excipients — q.s.
Approved Colour used — —
318 Ferrous Ascorbate, Folic acid and Zinc Sulphate Monohydrate Tablets
Composition Standard Quantity
Each film coated tablet contains:
Ferrous Ascorbate
(eq. to Elemental Iron)		 — 100 mg
Folic Acid I.P. 1.5 mg
Zinc Sulphate Monohydrate
(eq. to Elemental Zinc)		 I.P. 22.5 mg
Excipients — q.s.
Approved Colour used — —
319 Aceclofenac, Paracetamol and Thiocolchicoside Tablets
Composition Standard Quantity
Each film coated tablet contains:
Aceclofenac I.P. 100 mg
Paracetamol I.P. 325 mg
Thiocolchicoside I.P. 4 mg
Excipients — q.s.
Approved Colour used — —
320 Ursodeoxycholic Acid Tablets
Composition Standard Quantity
Each film coated tablet contains:
Ursodeoxycholic Acid I.P. 300 mg
Excipients — q.s.
Approved Colour used — —
321 Aceclofenac, Paracetamol and Serratiopeptidase Tablets (Warning: Overdose of this drug has potential of severe liver injury & allergic reactions (e.g. swelling of face, mouth & throat, difficulty in breathing, itching or rashes)
Composition Standard Quantity
Each film coated tablet contains:
Aceclofenac I.P. 100 mg
Paracetamol I.P. 325 mg
Serratiopeptidase
(eq. to enzymatic activity 20,000 units)
(as enteric coated granules) 		I.P. 10 mg
Excipients — q.s.
Approved Colour used — —
322 Aceclofenac, Paracetamol and Serratiopeptidase Tablets (Warning: Overdose of this drug has potential of severe liver injury & allergic reactions (e.g. swelling of face, mouth & throat, difficulty in breathing, itching or rashes)
Composition Standard Quantity
Each film coated tablet contains:
Aceclofenac I.P. 100 mg
Paracetamol I.P. 325 mg
Serratiopeptidase
(eq. to enzymatic activity 30,000 units)
(as enteric coated granules) 		I.P. 15 mg
Excipients — q.s.
Approved Colour used — —
323 Aceclofenac, Paracetamol and Chlorzoxazone Tablets (Warning: Overdose of this drug has potential of severe liver injury & allergic reactions (e.g. swelling of face, mouth & throat, difficulty in breathing, itching or rashes)
Composition Standard Quantity
Each film coated tablet contains:
Aceclofenac I.P. 100 mg
Paracetamol I.P. 325 mg
Chlorzoxazone U.S.P. 250 mg
Excipients — q.s.
Approved Colour used — —
324 Aceclofenac and Paracetamol Tablets
Composition Standard Quantity
Each film coated tablet contains:
Aceclofenac I.P. 100 mg
Paracetamol I.P. 325 mg
Excipients — q.s.
Approved Colour used — —
325 Aceclofenac and Thiocolchicoside Tablets
Composition Standard Quantity
Each film coated tablet contains:
Aceclofenac I.P. 100 mg
Thiocolchicoside I.P. 4 mg
Excipients — q.s.
Approved Colour used — —
326 Telmisartan and Amlodipine Besilate Tablets I.P
Composition Standard Quantity
Each uncoated tablet contains:
Telmisartan I.P. 40 mg
Amlodipine Besilate eq. to Amlodipine I.P. 5 mg
Excipients — q.s.
Approved Colour used — —
327 Etoricoxib and Thiocolchicoside Tablets
Composition Standard Quantity
Each film coated tablet contains:
Etoricoxib I.P. 60 mg
Thiocolchicoside I.P. 4 mg
Excipients — q.s.
Approved Colour used — —
328 Montelukast and Levocetirizine Tablets I.P
Composition Standard Quantity
Each film coated tablet contains:
Montelukast Sodium eq. to Montelukast I.P. 10 mg
Levocetirizine Hydrochloride I.P. 5 mg
Excipients — q.s.
Approved Colour used — —
329 Alpha Lipoic Acid, Folic Acid, Methylcobalamin, Pyridoxine HCl and Vitamin D3 Tablets
Composition Standard Quantity
Each film coated tablet contains:
Alpha Lipoic Acid USP 100 mg
Folic Acid I.P 1.5 mg
Methylcobalamin I.P 1500 mcg
Pyridoxine Hydrochloride I.P 3 mg
Vitamin D3 I.P 1000 IU
Excipients — q.s.
Approved Colour used — —
330 Paracetamol, Phenylephrine HCl, Diphenhydramine HCl and Caffeine Tablets
Composition Standard Quantity
Each chewable film-coated tablet contains :
Fexofenadine Hydrochloride I.P. 120 mg
Montelukast Sodium eq. to Montelukast I.P. 10 mg
Excipients q.s.
Approved Colour used
331 Levetiracetam Tablets I.P 500 mg
Composition Standard Quantity
Each film coated tablet contains:
Levetiracetam I.P 500 mg
Excipients — q.s.
Approved colour used — —
332 Ketoconazole Tablets I.P 200mg
Composition Standard Quantity
Each film coated tablet contains:
Ketoconazole I.P 200 mg
Excipients — q.s.
Approved colour used — —
333 Aceclofenac & Drotaverine HCl Tablets
Composition Standard Quantity
Each film coated tablet contains:
Aceclofenac I.P 100 mg
Drotaverine Hydrochloride I.P 80 mg
Excipients — q.s.
Approved Colour used — —
334 Etodolac and Paracetamol Tablets
Composition Standard Quantity
Each film coated tablet contains:
Etodolac I.P 400 mg
Paracetamol I.P 325 mg
Excipients — q.s.
Approved Colour used — —
335 Amisulpiride Tablets I.P 100 mg
Composition Standard Quantity
Each film coated tablet contains:
Amisulpride I.P 100 mg
Excipients — q.s.
Approved colour used — —
336 Etodolac ER Tablets 400MG
Composition Standard Quantity
Each film coated extended release tablet contains:
Etodolac I.P 400 mg
Excipients — q.s.
Approved Colour used — —
337 Nimesulide Tablets (Not to be used for children below 12 years of age)
Composition Standard Quantity
Each uncoated tablet contains :
Nimesulide B.P. 100 mg
Excipients q.s.
Approved Colour used
338 Methylcobalamin, Alpha Lipoic Acid, Inositol, Folic Acid, Chromium Polynicotinate, Selenium Dioxide and Benfotiamine Capsules
Ingredient Standard Quantity
Methylcobalamin I.P 1500 mcg
Alpha Lipoic Acid USP 100 mg
Inositol USP 100 mg
Folic Acid I.P 1.5 mg
Chromium Polynicotinate USP 200 mcg
Selenium Dioxide B.P 55 mcg
Benfotiamine USP 150 mg
Excipients — q.s.
Approved colour used in empty capsule shells — —

Explore Our List

Send Query





    two × five =

    Mail Us For Best Products





      three × 5 =

      Hot Line

      +91-8351823187

      E-mail Address

      krisa.healthcare@gmail.com

      Quick Contact

      Manufacturing Unit:- Plot No 6, Apparel Park Cum Industrial Area, Katha, Baddi-173205 (H.P.)

      +91-8351823187

      krisa.healthcare@gmail.com

      Follow Us On:-

      Copyrights © 2026, Krisa Healthcare
      Design & developed By Hivends Info Solutions